Invesco Nasdaq Biotechnology ETF Rating $29.25 +0.48 (+1.67%) As of 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.71Holdings in IBBQ have an aggregate rating of Moderate Buy based on 521 analyst ratings issued in the past year covering 25 companies (61.0% of the portfolio).IBBQ Aggregate Price Target$29.25High Prediction$29.25Average Prediction$29.25Low Prediction$29.25Holdings in IBBQ have an aggregate price target of $29.25 and a range of $29.25 to $29.25 covering 25 companies (61.0% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBBQ Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.49%GILDGilead Sciences$125.50-2.0%4.9178 of 5 stars2.86$156.93 25.0%29Trending NewsAnalyst Forecast7.38%VRTXVertex Pharmaceuticals$445.77+0.6%4.5977 of 5 stars2.88$555.91 24.7%25Positive NewsInsider Trade7.10%AMGNAmgen$344.57-0.3%4.1911 of 5 stars2.48$353.81 2.7%31Positive NewsAnalyst Downgrade5.14%REGNRegeneron Pharmaceuticals$616.18+0.8%4.8363 of 5 stars2.70$792.65 28.6%27Positive NewsGap Up3.22%ALNYAlnylam Pharmaceuticals$297.69+1.9%4.608 of 5 stars2.85$463.13 55.6%26Positive News2.44%RVMDRevolution Medicines$149.55+0.7%1.707 of 5 stars3.00$123.72 -17.3%222.29%BIIBBiogen$199.10+3.4%3.7145 of 5 stars2.55$217.26 9.1%29Analyst Upgrade1.96%UTHRUnited Therapeutics$553.14+1.6%4.2179 of 5 stars2.85$619.42 12.0%13Insider Trade1.93%ILMNIllumina$160.03+1.3%2.2746 of 5 stars2.28$138.38 -13.5%18Positive NewsInsider Trade1.89%ARGXargenex$884.00+0.2%3.9591 of 5 stars2.92$1,019.50 15.3%241.86%INSMInsmed$99.04+5.2%3.3489 of 5 stars2.96$212.50 114.6%25News CoveragePositive NewsAnalyst Forecast1.86%RPRXRoyalty Pharma$55.63+1.4%4.5629 of 5 stars3.00$53.71 -3.4%7Positive News1.70%ROIVRoivant Sciences$29.05+2.0%2.7821 of 5 stars2.75$33.59 15.6%12Positive News1.54%INCYIncyte$103.23+2.6%3.7444 of 5 stars2.32$105.10 1.8%22Trending NewsAnalyst Forecast1.50%MRNAModerna$47.73+0.3%1.4087 of 5 stars1.83$36.60 -23.3%18Trending NewsAnalyst ForecastInsider Trade1.48%VTRSViatris$16.20+1.7%2.9438 of 5 stars2.43$17.50 8.0%71.39%GHGuardant Health$130.12+4.2%2.0501 of 5 stars2.95$139.80 7.4%22Analyst ForecastInsider Trade1.25%NBIXNeurocrine Biosciences$165.24+1.3%3.7182 of 5 stars2.87$187.52 13.5%23Insider Trade1.16%ASNDAscendis Pharma A/S$213.23+3.6%4.6619 of 5 stars3.00$295.39 38.5%19News CoveragePositive NewsAnalyst Forecast1.15%JAZZJazz Pharmaceuticals$229.19-1.2%3.8779 of 5 stars2.84$244.18 6.5%19Positive NewsAnalyst Forecast1.07%SMMTSummit Therapeutics$14.29+1.3%3.3088 of 5 stars2.39$26.05 82.3%18Gap Up1.06%BBIOBridgeBio Pharma$67.68+0.5%3.724 of 5 stars2.85$89.59 32.4%26Insider Trade1.06%EXELExelixis$52.99+2.4%2.8334 of 5 stars2.39$47.35 -10.6%231.02%IONSIonis Pharmaceuticals$74.58+1.4%3.52 of 5 stars2.90$100.90 35.3%211.01%MEDPMedpace$466.79+1.9%2.1174 of 5 stars2.20$467.08 0.1%15 This page (NASDAQ:IBBQ) was last updated on 6/9/2026 by MarketBeat.com Staff. From Our PartnersJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBBQ Stock Alerts